Axinn is proud to be participating in the 72nd ABA Antitrust Law Spring Meeting and other adjacent events. The Spring Meeting is the...

The law of patent eligibility was pretty quiet for decades until the Supreme Court breathed new life into Section 101 invalidity...

Maryanne Magnier and I have drafted an article titled, “The Rise of Labor Issues as an Antitrust Priority.” The article will soon appear...

Puma Biotechnology is the latest victim of standing requirements in patent cases that continue to wreak havoc on plaintiffs’ ability to...

A recent decision reported by Law360 is a useful reminder of the power of a remedy peculiar to Connecticut courts, the prejudgment remedy...

Earlier this month, I previewed a Federal Circuit oral argument in In re: California Expanded Metal Products Co., No. 2023-1140, where...

Today's speech by Guillaume Loriot -- the EC's Deputy Director General for Mergers -- is worth a read. Without agreeing necessarily with...

This is part one of our USITC Commissioner Series. Read part two here, part three here, part four here and part five here.  At the...

We were so pleased to have the opportunity to address InformaMarkets’ 13th Annual Pharma IPR Conference in Mumbai on legal challenges to...

On March 12, 2024, the Judicial Conference of the United States announced an amendment of the policy governing random case assignment to...

  As we navigate the ever-evolving terrain of technology and market dynamics, it’s vital to stay ahead with insights that transcend the...

The 2024 ABA White Collar Crime Conference in San Francisco was filled with insightful discussion on hot topics in recent U.S. criminal...

We just returned from a weeklong trip to Mumbai in which Axinn served as the Platinum sponsor of InformaMarkets 13th Annual Pharma IPR...

In almost every way, the party of the U.S. President controls federal antitrust enforcement policy. The one exception is control over...

Earlier today the Federal Circuit in Maxell v. Amperex, No. 23-1194, vacated a District Court’s indefiniteness determination after...

Jason Murata joins Richard Hsu on the Hsu Untied podcast to discuss his background in biochemistry and biotechnology, how he launched his...